Westlake Precision Nutrition Study 2 (WePrecision2)
WePrecision2
1 other identifier
interventional
49
1 country
1
Brief Summary
This is a dietary intervention study, which aims to explore different diet challenges for glucose metabolism, including carbohydrates and fasting dietary pattern. Considering the glucose responses to the same food are largely heterogeneous among people, this study integrates the concepts of precision nutrition and N-of-1 design. The study also aims to discover the different impact of the time-restricted diet (TRD) and the energy-restricted diet (ERD) on host metabolic health and our hair growth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2023
CompletedFirst Posted
Study publicly available on registry
April 6, 2023
CompletedStudy Start
First participant enrolled
May 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2023
CompletedMay 31, 2023
March 1, 2023
11 days
March 23, 2023
May 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Blood glucose profiling
Real-time blood glucose fluctuations will be recorded by CGM.
14 days
Change of glucose tolerance before and after intermittent fasting
Oral glucose tolerance test will also be conducted.
Day 2 and Day 13
Other Outcomes (11)
Changes of fecal and urine metabolomics profiling
Day 2 and Day 13
Changes of serum metabolomics profiling
Day 2 and Day 13
Changes of interleukin-1β (IL-1β), IL-6, IL-12
Day 2 and Day 13
- +8 more other outcomes
Study Arms (4)
refined carbohydrate breakfast (Breakfast A)
EXPERIMENTALwhite bread (50g) + milk powder (25g)
whole grain breakfast (Breakfast B)
EXPERIMENTALplain oats (35g) + milk powder (25g)
Energy-restricted diet
EXPERIMENTALtime-restricted diet
EXPERIMENTALInterventions
After completing the baseline data and biological sample collection, the ERD group volunteers underwent a 10-day dietary intervention from day 3 to day 12. During this period, a standard breakfast was provided to all volunteers daily by the research staff through the school cafeteria. The ERD group volunteers still had their lunch and dinner provided by the research staff through the school cafeteria to ensure their daily energy intake was controlled between 1200-1500 kcal.
After wearing CGM on Day 1, participants will be provided with breakfast A once daily on Day 3, Day 4, Day 7, Day 8, Day 10, Day 12. Breakfast A contains white bread (50g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
After wearing CGM on Day 1, participants will be provided with Breakfast B once daily on Day 5, Day 6, Day 9, Day 11. Breakfast B contains plain oats (35g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
After completing the baseline data and biological sample collection, the volunteers in the TRD group will undergo a 10-day dietary intervention from day 3 to day 12. The TRD group needs to adjust their breakfast eating time to after 10:00 am daily, and they are free to choose their own lunch and dinner according to their dietary habits but must finish their meals before 4:00 pm. During this time window, no other energy-providing foods should be consumed.
Eligibility Criteria
You may qualify if:
- Participants have completed WePrecision trial in 2021
- Participants reside in Hangzhou
- Participants have no traveling plans within 3 months
You may not qualify if:
- Participants with metabolic diseases including diabetes, hypertension and cardiovascular diseases (CVD)
- Participants with craniocerebral trauma, cancer, liver disease, kidney disease, or other critical illness, or history of operation or medication
- Participants with bulimia nervosa, post-traumatic stress disorder (PTSD), chronic anxiety and depression or other critical neuronal disorder or history of relevant medication
- Being or to be pregnant or lactating.
- Participants with history of alcohol or drug addiction, or smoke above 15 cigarettes per day
- Concurrently participating other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westlake University
Hangzhou, Zhejiang, 310058, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ju-Sheng Zheng, PhD
Westlake University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2023
First Posted
April 6, 2023
Study Start
May 8, 2023
Primary Completion
May 19, 2023
Study Completion
May 19, 2023
Last Updated
May 31, 2023
Record last verified: 2023-03